Decision regret after external beam radiotherapy and high dose-rate brachytherapy boost for prostate cancer.

ABSTRACT:

Purpose

Patients with localized prostate cancer have various treatment options. Decision regret from a patient's view is an unpleasant feeling concerning a decision in health care. We aimed to explore regret and its determinants after external beam radiotherapy (EBRT) with a high dose-rate brachytherapy (HDR-BT) boost as traditional method of treatment intensification.

Methods

We conducted a secondary analysis of a cross-sectional study. Patients were enrolled at least two years after EBRT + HDR-BT. Decision regret was measured using the Decision Regret Scale (0-100). Covariables included patient characteristics, dose to organs at risk and patient-reported outcomes (PRO) including EPIC- 26, EORTC QLQ-C30, and PSCC. We used Pearson's correlation and one-way ANOVA analyses.

SUBMITTER: Haack L 

PROVIDER: S-EPMC11982119 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature